The role of the microbiome in NAFLD and NASH
Open accessThe DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of cardiometabolic syndrome, which often also includes obesity, diabetes, and dyslipidemia. It is rapidly becoming the most prevalent liver disease worldwide. A sizable minority of NAFLD patients develop nonalcoholic steatohepatitis (NASH), which is characterized by inflammatory changes that can lead to progressive liver damage, cirrhosis, and hepatocellular carcinoma. Recent studies have shown that in addition to genetic predisposition and diet, the gut microbiota affects hepatic carbohydrate and lipid metabolism as well as influences the balance between pro‐inflammatory and anti‐inflammatory effectors in the liver, thereby impacting NAFLD and its progression to NASH. In this review, we will explore the impact of gut microbiota and microbiota‐derived compounds on the development and progression of NAFLD and NASH, and the unexplored factors related to potential microbiome contributions to this common liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activation of these TLRs can contribute to the development of NAFLD and nonalcoholic steatohepatitis (NASH), with the most extensively studied pathway being LPS-TLR4 signaling.180”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [180]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 2×
“However, conven-tionalization of germ-free mice with normal mouse microbiota induces de novo hepatic lipogenesis, in addition to increased body fat content and insulin resistance (Ba¨ckhed et al , 2004).”
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952 · cited 1×
“Under physiological conditions, tight junction proteins, such as zonula occludens, seal adjacent epithelial cells at the apical sites and prevent bacteria from entering the intestinal mucosa and the bloodstream (Turner, 2009).”
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788 · cited 1×
“…in the digestion of food and facilitates the absorption of the dietary molecules into the portal and systemic circulation (Jumpertz et al , 2011; Ridaura et al , 2013), interacts with the mucosal immune system, to shape development of its antigen recognition, recruitment, proliferation, and…”
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241 · cited 3×
“In addition, SCFAs are also potent signaling molecules through binding to G-protein-coupled receptors GPR41, GPR43, and GPR109A (Samuel et al , 2008; Maslowski et al , 2009).”
Research works printed but not linked: 1
- Ackermann D, Schutze H (1910) The formation of trimethylamine by bacterium prodigiosum. Zentralb Physiol 24: 210–211
Cited by
Items 301–400 of 548
Ye, M., He, Y., Xia, Y. Y., Zhong, Z., Kong, X., Zhou, Y., Wang, W., Qin, S., & Li, Q. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03547-7 · Cited by 13
Xu, Q.-Y., Li, H., Cao, H., Pan, Q., & Fan, J. (2020) · BioMed Research International · doi:10.1155/2020/8869674 · Cited by 13
Macrophages as a source of fibrosis biomarkers for non-alcoholic fatty liver disease
Yoshio, S., & Kanto, T. (2021) · Immunological Medicine · doi:10.1080/25785826.2020.1868664 · Cited by 14
The Impact of Dietary Patterns and Nutrition in Nonalcoholic Fatty Liver Disease
Kim, A., Krishnan, A., Hamilton, J. P., & Woreta, T. A. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2020.10.013 · Cited by 13
Gallego‐Durán, R., Albillos, A., Ampuero, J., Arechederra, M., Bañares, R., Blas‐García, A., Berná, G., Caparrós, E., Delgado, T. C., Falcón‐Pérez, J. M., et al. (2022) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2022.02.005 · Cited by 17
Chen, S., Zhu, H.-L., & Luo, Y. (2022) · Current Opinion in Food Science · doi:10.1016/j.cofs.2022.100972 · Cited by 13
Microbiota–Liver Diseases Interactions
Capparelli, R., Cuomo, P., Gentile, A., & Iannelli, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043883 · Cited by 14
Mini review: STING activation during non-alcoholic fatty liver disease
Li, H., Guo, X., Aquino, E., & Wu, C. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1139339 · Cited by 16
Natural Products for the Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review
Nucera, S., Bulotta, R. M., Ruga, S., Caminiti, R., Serra, M. D. R., Bava, R., Castagna, F., Lupia, C., Marrelli, M., Conforti, F., et al. (2023) · Scientia Pharmaceutica · doi:10.3390/scipharm91040053 · Cited by 13
Kim, K., & Kim, K. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072296 · Cited by 13
Lee, K. S., Cho, Y., Kim, H., Hwang, H., Cho, J. W., Lee, Y., & Lee, S.-G. (2022) · Biomedicines · doi:10.3390/biomedicines10061216 · Cited by 14
You, H., Deng, X., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2022) · Marine Drugs · doi:10.3390/md20070444 · Cited by 13
Zhang, Z., Qin, X., Yi, T., Li, Y., Li, C., Zeng, M., Luo, H., Lin, X., Xie, J., Xia, B., et al. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300845 · Cited by 12
Gut microbiome in non-alcoholic fatty liver disease
Mpountouridis, A., Tsigalou, C., Bezirtzoglou, I., Bezirtzoglou, E., & Stavropoulou, E. (2025) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2024.1534431 · Cited by 15
Zhao, F., Ke, J., Pan, W., Pan, H., & Shen, M. (2022) · Molecular Medicine · doi:10.1186/s10020-021-00428-7 · Cited by 12
Alomari, M., Rashid, M. U., Chadalavada, P. N., Ragheb, J. G., Zafar, H., Suarez, Z. K., Khazaaleh, S., Gonzalez, A. J., & Castro, F. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i4.477 · Cited by 13
Zhu, S., Wu, Z., Wang, W., Wei, L., & Zhou, H. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02216-y · Cited by 12
Transfer Learning versus Custom CNN Architectures in NAFLD Biopsy Images
Arjmand, A., Christou, V., Tzallas, A. T., Tsipouras, M. G., Angelis, C. T., Tsoumanis, G., Glavas, E., Forlano, R., Manousou, P., & Γιαννακέας, Ν. (2020) · International Conference on Telecommunications and Signal Processing (TSP) · doi:10.1109/tsp49548.2020.9163489 · Cited by 12
Ye, M., Tang, Y., He, J., Yang, Y., Cao, X., Kou, S., Wang, L., Sheng, L., & Xue, J. (2021) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2020.12.007 · Cited by 15
Liu, J., Yu, W., Wang, C., Li, S., & Zhang, W. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105342 · Cited by 12
Using epigenomics to understand cellular responses to environmental influences in diseases
Wattacheril, J. J., Raj, S. M., Knowles, D. A., & Greally, J. M. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010567 · Cited by 14
Joon, A., Sharma, A., Jalandra, R., Bayal, N., Dhar, R., & Karmakar, S. (2024) · Journal of Translational Gastroenterology · doi:10.14218/jtg.2023.00018 · Cited by 12
Small intestinal bacterial overgrowth and metabolic dysfunction-associated steatotic liver disease
Wang, Z., Tan, W., Huang, J., Li, Q., Wang, J., Su, H., Guo, C., & Liu, H. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1502151 · Cited by 11
Zhang, S., Zhao, R., Wang, R., Lu, Y., Xu, M., Lin, X., Lan, R., Zhang, S., Tang, H., Fan, Q., et al. (2025) · Nutrients · doi:10.3390/nu17091585 · Cited by 11
Gu, M., Hong, Q., Cui, J., Li, W., Zhang, J., Sun, Y., Jiang, J., & Hu, Y. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2504162 · Cited by 11
Triclosan targeting of gut microbiome ameliorates hepatic steatosis in high fat diet-fed mice
Sun, D., Zuo, C., Huang, W., Wang, J., & Zhang, Z. (2022) · The Journal of Antibiotics · doi:10.1038/s41429-022-00522-w · Cited by 11
The effects of the voglibose on non-alcoholic fatty liver disease in mice model
Bae, J., Lee, J. Y., Shin, E., Lee, M., Lee, Y., Lee, B., Kang, E. S., & Soo, B. (2022) · Scientific Reports · doi:10.1038/s41598-022-15550-7 · Cited by 11
Chang, B. Y., Bae, J. H., Lim, C. Y., Kim, Y. H., Kim, T. Y., & Kim, S. Y. (2023) · Food Science and Biotechnology · doi:10.1007/s10068-023-01311-3 · Cited by 12
Impact of fasting on human health during Ramadan
Shah, J. A., Rahman, M. U., Sidikov, A. S., Sikandar, P. S., & Yerian, A. D. (2023) · International Journal of Public Health Science (IJPHS) · doi:10.11591/ijphs.v12i4.23062 · Cited by 11
Wang, S., Zhang, R., Guo, P., Yang, H., Liu, Y., & Zhu, H. (2025) · The EPMA Journal · doi:10.1007/s13167-025-00398-4 · Cited by 11
Hepatocellular Carcinoma: Understanding the Inflammatory Implications of the Microbiome
Khalyfa, A. A., Punatar, S., & Yarbrough, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158164 · Cited by 13
Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease
Jeong, M. K., Min, B. H., Choi, Y. R., Hyun, J. Y., Park, H., Eom, J. A., Won, S. M., Jeong, J., Oh, K., Gupta, H., et al. (2022) · Foods · doi:10.3390/foods11172703 · Cited by 11
D’Errico, A., Riefolo, M., Serenari, M., Pace, V. D., Santandrea, G., Monica, M. A. T., Cillia, C. D., Ravaioli, M., Cescon, M., & Vasuri, F. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.05.013 · Cited by 11
Yamamoto, K., Honda, T., Yokoyama, S., Ma, L., Kato, A., Ito, T., Ishizu, Y., Kuzuya, T., Nakamura, M., Kawashima, H., et al. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.02.013 · Cited by 11
Yu, H., Zhang, Y., Chen, J., Jiang, S., Zheng, Y., Xu, Y., Li, Y., Kong, J., Yu, X., & Du, H. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.03.039 · Cited by 10
Metabolic dysfunction-associated steatotic liver disease in people with HIV
Gattu, A. K., & Fourman, L. T. (2025) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000952 · Cited by 11
Dong, H., Yang, X., Zhou, Y., Yang, M. Q., Zhang, H., Liu, X., & Zhu, W. (2025) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.14371 · Cited by 10
Nutrigenomics of fat-soluble vitamins and micronutrients in hepatocyte lipotoxicity and MASLD
Migni, A., Bartolini, D., Ceccarini, M. R., Galli, C., Cavaliere, G., Garetto, S., Lucci, J., & Galli, F. (2026) · Progress in Lipid Research · doi:10.1016/j.plipres.2026.101380 · Cited by 10
Role of acetylation in nonalcoholic fatty liver disease: a focus on SIRT1 and SIRT3
Nassir, F. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00017 · Cited by 10
What Does Sarcopenia Have to Do with Nonalcoholic Fatty Liver Disease?
Ferenc, K., Jarmakiewicz-Czaja, S., & Filip, R. (2023) · Life · doi:10.3390/life14010037 · Cited by 10
Yang, J., Ou, W., Lin, G., Wang, Y., Chen, D., Zeng, Z., Chen, Z., Lu, X., Wu, A., Lin, C., et al. (2024) · Nutrients · doi:10.3390/nu16223837 · Cited by 10
Site-specific impact of polyphenols on the gastrointestinal microbiome
Ebrahimi, F., Subbiah, V., Ağar, O. T., Legione, A. R., & Suleria, H. A. R. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2434961 · Cited by 11
L’homme, L., Sermikli, B. P., Molendi‐Coste, O., Fleury, S., Quemener, S., Maître, M. L., Joseph, M.-L., Pineau, L., Duhem, C., Gross, B. S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77858-6 · Cited by 10
Yang, Y., Jiang, X., Pandol, S. J., Han, Y., & Zheng, X. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.739174 · Cited by 10
Liakina, V., Strainienė, S., Stundienė, I., Maksimaityte, V., & Kazėnaitė, E. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i7.1277 · Cited by 11
Prebiotic effect of poly‐D ‐3‐hydroxybutyrate prevents dyslipidemia in obese mice
Mishima, M., Takeda, S., Nagane, M., Suzuki, T., Ogata, M., Shima, A., Aihara, N., Kamiie, J., Suzuki, R., Mizugaki, H., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202301191r · Cited by 10
Mining Gut Microbiota From Bariatric Surgery for MAFLD
Wu, W., Chen, Y., Lee, P., Yang, P., Chang, C., Liu, K., Hsu, C., Huang, C., Chuang, H.-L., Sheen, L., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.612946 · Cited by 13
Yang, J., Xiaolei, T., Chen, L., Hu, J., Li, S., Yuan, M., Tian, X., & Qiu, Z. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673276581231210170332 · Cited by 9
Song, W., Hu, J., Zhu, L., Chen, B., Li, L., Cui, X., Zhang, T., Miao, Y., Su, K., Liu, C., et al. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250040 · Cited by 9
Lin, Y., Fang, Q., Fu, S.-N., Li, X., Shi, R., Du, C., Qiao, X., Yin, X., Zeng, Y.-C., Zhao, X., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1143785 · Cited by 9
Deng, J., Qin, L., Qin, S., Wu, R., Huang, G., Fang, Y., Huang, L., & Zhou, Z. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s448723 · Cited by 9
Klag, K. A., Bell, R. S., Jia, X., Seguin, A., Maschek, J. A., Bronner, M. P., Cox, J. E., Round, J. L., & Ward, D. M. (2024) · Nutrients · doi:10.3390/nu16121804 · Cited by 9
Src kinase as a potential therapeutic target in non‐alcoholic and alcoholic steatohepatitis
Kurniawan, D. W., Booijink, R. S., Jajoriya, A. K., Dhawan, G., Mishra, D., Oosterhuis, D., Argemí, J., Storm, G., Olinga, P., Bataller, R. A., et al. (2022) · Clinical and Translational Discovery · doi:10.1002/ctd2.18 · Cited by 9
Nie, W., Yang, Y., Li, L. J., Ding, Y., Chen, X., Li, M., He, N., Ji, G., Zhang, Y., Kang, P., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1174742 · Cited by 9
Zhang, T., Gao, H., Fan, Y., Chen, S., Li, Y., Liu, R., Li, T., & Yin, C. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121912 · Cited by 9
Azulai, S., Grinbaum, R., Beglaibter, N., Eldar, S. M., Rubin, M., Carmi, S., Schyr, R. B., Romano‐Zelekha, O., & Ben‐Zvi, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122724 · Cited by 11
Liu, J., Chen, Y., Cen, Z., Hong, M., Zhang, B., Luo, X., Wang, L., Li, S., Xiao, X., & Long, Q. (2025) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2025.116674 · Cited by 8
Rastogi, S., Bachhar, V., Joshi, V., Kumar, S., Panjwani, D., Singh, L., & Haldhar, R. (2025) · 3 Biotech · doi:10.1007/s13205-025-04322-5 · Cited by 8
Li, T., & Jing, W. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1565778 · Cited by 8
Liu, H., Xu, X., Yao, Z., Kang, J., Shen, Y., & Liu, W. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1598664 · Cited by 8
Gut microbiota as a metabolic mediator to prevent or attenuate MASLD
Luo, J., Wei, Y., Fan, Z., Li, B., Li, L., Chai, Y., Xing, Z., Qiu, Y., Lu, W., & Fang, Z. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2545525 · Cited by 9
From model to man: Understanding Tregs' dual role in MASLD
Dywicki, J., Buitrago‐Molina, L. E., Baumann, A. K., Davalos‐Misslitz, A. C. M., Hendriks, C. M., Hupa‐Breier, K. L., Lieber, M., Schlué, J., Blüher, M., Bantel, H., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101619 · Cited by 8
Li, Z., Zhu, X., Li, C., Tang, R., Zou, Y., & Liu, S. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118526 · Cited by 8
Noor, S., Ali, S., Summer, M., Riaz, A., Nazakat, L., & Aqsa, A. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10365-6 · Cited by 8
Niu, Q., Xi, Y.-T., Li, Z., Zhang, C., Li, X.-Y., Li, C.-Z., Wang, H.-D., Zhang, M.-X., zhu, M., & Li, P. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177092 · Cited by 8
Fikry, H., Saleh, L. A., Sadek, D. R., & Abd-Alkhalek, H. A. (2024) · Cell and Tissue Research · doi:10.1007/s00441-024-03927-1 · Cited by 8
The liver-gut axis perspective: Exploring the pathogenesis of fatty liver
Yang, Z., Zhang, J., Liu, X., Chen, H., Duan, H., Wang, Q., Zhao, W., & Jin, L. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177822 · Cited by 8
Intestinal microbiota in the treatment of metabolically associated fatty liver disease
Wang, J.-S., & Liu, J. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i31.11240 · Cited by 9
Dioletis, E., Paiva, R., Kaffe, E., Secor, E. R., Weiss, T. R., Fields, M. R., Ouyang, X., & Ali, A. (2021) · BMC Nutrition · doi:10.1186/s40795-021-00408-4 · Cited by 9
The role of gut microbiota in non-alcoholic fatty liver disease pathogenesis
Yaghmaei, H., Nojoumi, S. A., Soltanipur, M., Yarmohammadi, H., Mirhosseini, S. M., Rezaei, M., Nadoushan, M. J., & Siadat, S. D. (2024) · Obesity Medicine · doi:10.1016/j.obmed.2024.100551 · Cited by 7
Kohli, I., Sohal, A., Patel, J., & Roytman, M. M. (2024) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-5409 · Cited by 7
Zhou, A., Peng, N., Yang, L., Yang, S., & Wang, J. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04151-9 · Cited by 7
Crocetta, A., Giannelou, M.-A., Benfante, A., Castelli, L., & Koumbi, L. (2025) · Livers · doi:10.3390/livers5030043 · Cited by 8
Barrea, L., Verde, L., Galasso, M., Savastano, S., Colao, A., & Muscogiuri, G. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07295-4 · Cited by 7
Wang, L., Xu, J., You, N., Shao, L., Zhuang, Z., Zhuo, L., Liu, J., & Shi, J. (2024) · Lipids · doi:10.1002/lipd.12410 · Cited by 7
Li, J., Zhao, Z., Deng, Y., Li, X., Zhu, L., Wang, X., Li, L., & Li, X. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4612 · Cited by 8
Huang, Z., Chang, Y., Hao, K., Tan, Y., Ding, L., Wang, L., Wang, Z., Pan, Z., Gao, H., Wu, J., et al. (2023) · iMeta · doi:10.1002/imt2.100 · Cited by 7
Szczeklik, K., Owczarek, D., Cibor, D., Cześnikiewicz‐Guzik, M., Krzyściak, P., Krawczyk, A., Mach, T., Karczewska, E., & Krzyściak, W. (2019) · PubMed · doi:10.24425/fmc.2019.128023 · Cited by 7
Clostridioides difficile infection in patients with nonalcoholic fatty liver disease-current status
Kiseleva, Y. V., Maslennikov, R. V., Gadzhiakhmedova, A. N., Zharikova, T. S., Kalinin, D. V., & Zharikov, Y. O. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i2.208 · Cited by 8
Wang, S., Xu, H., Du, R., Wei, C., Cui, X., Zhang, C., Zhong, M., Zhang, H., Wu, Q., Tong, G., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120192 · Cited by 6
Guo, J., Shi, A., Sun, Y., Zhang, S., Feng, X., Chen, Y., & Yao, Z. J. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s507039 · Cited by 6
Alam, N., Ding, X., Fu, Y., Jia, L., Ali, S. M., & Liu, E. (2025) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00190.2024 · Cited by 7
Dong, Q., Wang, Y., He, Y., Gao, T., Li, L., Chen, L., Liu, C., Wang, W., Liu, X., Zhang, Y., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120269 · Cited by 10
Ganesan, R., & Suk, K. T. (2022) · Process Biochemistry · doi:10.1016/j.procbio.2022.10.031 · Cited by 6
An Efficient Liver Disease Prediction based on Deep Convolutional Neural Network using Biopsy Images
Bharathi, S., Balaji, A., Dolly Irene., J., Kalaivanan, C., & Anusuya, R. (2022) · International Conference on Smart Electronics and Communication (ICOSEC) · doi:10.1109/icosec54921.2022.9951870 · Cited by 6
Josol, V. J. D., Salvador, P. B. U., Cruz, L. L. A., Ornos, E. D. B., & Tantengco, O. A. G. (2023) · Obesity Medicine · doi:10.1016/j.obmed.2023.100527 · Cited by 6
GLP-1/GLP-1RAs: New Options for the Drug Treatment of NAFLD
Jiang, H., & Zang, L. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128283153231226103218 · Cited by 7
Fakhoury-Sayegh, N., Hamdan, A., Lebbos, S., Itani, T. M., Trak-Smayra, V. E., Khazzaka, A., Dagher‐Hamalian, C., Sayegh, L. N., Mallah, M., Obeid, O., et al. (2024) · Nutrients · doi:10.3390/nu16111701 · Cited by 6
Xiao, P., Ye, Z., Li, X., Feng, Q., & Su, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1540255 · Cited by 7
Effects of pine pollen wall on gut microbiota and biomarkers in mice with dyslipidemia
Song, X., Wang, Y., Guan, R., Ma, N., Yin, L., Zhong, M., Wang, T., Shi, L., & Geng, Y. (2020) · Phytotherapy Research · doi:10.1002/ptr.6952 · Cited by 6
Beydoun, S., Fardous, A. M., Saruna, M. M., Beydoun, A. G., Sorge, J. A., Ma, H., Aoun, G., Unnikrishnan, A., Cabelof, D. C., & Heydari, A. R. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111387 · Cited by 6
Ye, M., Tang, Y., He, J., Yang, Y., Cao, X., Kou, S., Wang, L., Sheng, L., & Xue, J. (2021) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2021.09.001 · Cited by 6
Dietary Amino Acid Source Elicits Sex‐Specific Metabolic Response to Diet‐Induced NAFLD in Mice
Rives, C., Martin, C. M. P., Evariste, L., Polizzi, A., Huillet, M., Lasserre, F., Alquier‐Bacquie, V., Perrier, P., Gomez, J., Lippi, Y., et al. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300491 · Cited by 6
van Dijk, A., Dingerink, S., Chilunga, F. P., Meeks, K. A. C., Bahendeka, S., Schulze, M. B., Danquah, I., Osei, T. B., Serné, E. H., Agyemang, C. O., et al. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00066 · Cited by 6
Gut microbiome and non-alcoholic fatty liver disease
Purohit, A., Alam, J., Kandiyal, B., Shalimar, S., Das, B., & Banerjee, S. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.07.004 · Cited by 6
Maddineni, G., Obulareddy, S. J., Paladiya, R. D., Korsapati, R. R., Jain, S., Jeanty, H., Vikash, F., Tummala, N., Shetty, S., Ghazalgoo, A., et al. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002276 · Cited by 5
You, B., & Chen, Z. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1522219 · Cited by 5
Exploring LRP-1 in the liver-brain axis: implications for Alzheimer’s disease
Sharma, V. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10980-8 · Cited by 7
Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice
Dimet‐Wiley, A., Wu, Q., Wiley, J. T., Eswar, A., Neelakantan, H., Savidge, T., & Watowich, S. (2022) · Scientific Reports · doi:10.1038/s41598-021-03670-5 · Cited by 5
The relationship between folic acid and nonalcoholic fatty liver disease
Xu, B., Yang, X., Zhu, X., Liu, Q., Zhang, Y., Zhang, M., Fan, C., Ban, X., Aikebaier, G., & Bian, H. (2024) · Clinical and Translational Discovery · doi:10.1002/ctd2.274 · Cited by 5
Metadata
- Authors
- Kolodziejczyk, A. A., Zheng, D., Shibolet, O., & Elinav, E.
- Affiliations
- Weizmann Institute of Science (IL)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Tel Aviv Sourasky Medical Center (IL)
- Corresponding author
- Elinav, Eran
- Venue
- EMBO Molecular Medicine
- Published
- 2018-12-27
- Volume
- 11
- Issue
- 2
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC6365925
- OpenAlex
- W2907493655
- Cited by
- 523
- References
- 125
- Citations by year
- 2026: 30 · 2025: 63 · 2024: 73 · 2023: 94 · 2022: 91 · 2021: 76 · 2020: 71 · 2019: 25
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- EMBO Molecular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- European Union's Horizon 2020 (747114)
- European Crohn's and Colitis Organization (ECCO) Fellowship
- Ke Lin Program of the First Affiliated Hospital of Sun Yat‐sen University
- Alexander Grass foundation
- Y. and R. Ungar
- Gurwin Family Fund for Scientific Research
- Crown Endowment Fund for Immunological Research
- Else Kroener‐Fresenius Foundation
- Benoziyo Endowment Fund for the Advancement of Science
- Adelis Foundation
- French National Center for Scientific Research
- European Research Council
- Marie Curie Integration grant
- Rising Tide Foundation
- Helmholtz Foundation
- Canadian Institute of Advanced Research
- The Bill & Melinda Gates Foundation & Howard Hughes Medical Institute
- Abisch‐Frenkel Foundation for the Promotion of Life Sciences
- Leona M. and Harry B. Helmsley Charitable Trust
- German–Israeli Foundation for Scientific Research and Development
- Israel Science Foundation
- Minerva Foundation
- European Foundation for the Study of Diabetes
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, gut microbiota, microbiome, cardiometabolic syndrome, obesity, diabetes mellitus, dyslipidemia, hepatic lipid metabolism, hepatic carbohydrate metabolism, inflammation, gut microbiota metabolites, liver cirrhosis, hepatocellular carcinoma
- MeSH terms
- Gastrointestinal Microbiome, Bacteria, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Disease Progression, Carbohydrate Metabolism, Lipid Metabolism, Microbiota, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.